SUVENPHAR.NSE Suven Pharmaceuticals Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Suven Pharmaceuticals Ltd. market cap is 163.98B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Suven Pharmaceuticals Ltd. 52 week high is 768.00 as of May 20, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Suven Pharmaceuticals Ltd. 52 week low is 469.45 as of May 20, 2024.

Suven Pharmaceuticals Ltd. stock price today is 645.00.

Suven Pharmaceuticals Ltd. stock price yesterday was 644.00.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Suven Pharmaceuticals Ltd.’s P/E ratio is 44.21.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Suven Pharmaceuticals Ltd. P/B ratio is 8.4725.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Suven Pharmaceuticals Ltd.'s EBITDA is 27.30.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Suven Pharmaceuticals Ltd. 50-day moving average is 647.64.

Suven Pharmaceuticals Ltd. has 2,576 employees.